Skip to main content
. 2019 Apr 16;17(6):4670–4676. doi: 10.3892/etm.2019.7490

Figure 5.

Figure 5.

Expression of miR-146a in (A) liver tissues, (B) PBMCs and (C) serum of patients with hepatitis B and liver fibrosis or cirrhosis. Reverse transcription-quantitative polymerase chain reaction was used to determine miR-146a expression. Data are presented as the mean + standard deviation. *P<0.05; **P<0.01 vs. patients with liver fibrosis. PBMC, peripheral blood mononuclear cells; miR, microRNA.